RS20050911A - Gaboxadol for treating depression and other affective disorders - Google Patents

Gaboxadol for treating depression and other affective disorders

Info

Publication number
RS20050911A
RS20050911A YUP-2005/0911A YUP20050911A RS20050911A RS 20050911 A RS20050911 A RS 20050911A YU P20050911 A YUP20050911 A YU P20050911A RS 20050911 A RS20050911 A RS 20050911A
Authority
RS
Serbia
Prior art keywords
gaboxadol
treating depression
affective disorders
pharmaceutical composition
relates
Prior art date
Application number
YUP-2005/0911A
Other languages
English (en)
Inventor
Connie Sanchez
Bjarke Ebert
Original Assignee
H.Lundbeck A/S.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58707228&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS20050911(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H.Lundbeck A/S., filed Critical H.Lundbeck A/S.,
Priority claimed from PCT/DK2004/000459 external-priority patent/WO2004112786A2/en
Publication of RS20050911A publication Critical patent/RS20050911A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Sadašnji pronalazak se odnosi na upotrebu gaboksadola za pripremanje farmaceutskog sastava za lečenje depresije. Šta više, on se odnosi na upotrebu gaboksadola za pripremanje farmaceutskog sastava koji se ima upotrebiti u kombinaciji sa inhibitorom resorbcije serotonina ili bilo kojim jedinjenjem koje izaziva podizanje nivoa ekstracelularnog serotonina.
YUP-2005/0911A 2003-06-25 2004-06-25 Gaboxadol for treating depression and other affective disorders RS20050911A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200300956 2003-06-25
DKPA200400016 2004-01-07
PCT/DK2004/000459 WO2004112786A2 (en) 2003-06-25 2004-06-25 Gaboxadol for treating depression and other affective disorders

Publications (1)

Publication Number Publication Date
RS20050911A true RS20050911A (en) 2007-08-03

Family

ID=58707228

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-2005/0911A RS20050911A (en) 2003-06-25 2004-06-25 Gaboxadol for treating depression and other affective disorders

Country Status (10)

Country Link
KR (1) KR20060025192A (sr)
AR (1) AR047550A1 (sr)
CA (2) CA2529805A1 (sr)
CL (2) CL2004001607A1 (sr)
EA (1) EA200600101A1 (sr)
IS (1) IS8138A (sr)
ME (2) ME00030B (sr)
NO (1) NO20060229L (sr)
RS (1) RS20050911A (sr)
TW (1) TW200509918A (sr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3883566A4 (en) 2018-11-21 2022-09-07 Certego Therapeutics Inc. GABOXADOL FOR SUICIDE RISK REDUCTION AND RAPID DEPRESSION RELIEF
CA3182508A1 (en) 2020-05-20 2021-11-25 Certego Therapeutics Inc. Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders

Also Published As

Publication number Publication date
TW200509918A (en) 2005-03-16
MEP1908A (xx) 2010-02-10
KR20060025192A (ko) 2006-03-20
CL2004001607A1 (es) 2005-05-27
AR047550A1 (es) 2006-01-25
ME00030B (me) 2010-06-10
IS8138A (is) 2005-11-21
NO20060229L (no) 2006-01-16
CL2010000166A1 (es) 2010-07-02
EA200600101A1 (ru) 2006-06-30
CA2529805A1 (en) 2004-12-29
CA2692334A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
IL172631A0 (en) Gaboxadol for treating depression and other affective disorders
TW201713640A (en) Bruton's tyrosine kinase inhibitors
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
PL2134704T3 (pl) Związki i kompozycje pełniące rolę modulatorów aktywności GPR119
CL2008003407A1 (es) Compuestos derivados de aril- y heteroarilcarbonilo de heterobiciclo sustituido; composicion farmaceutica; procedimiento de preparacion; y su uso en el tratamiento y/o prevencion de trastornos metabolicos, mediado por la inhibicion de la enzima hsd-1.
MX359668B (es) Derivados de retinal y metodos para su uso en el tratamiento de trastornos visuales.
MX2007010560A (es) Roflumilast para el tratamiento de diabetes mellitus.
MX2009010960A (es) Compuestos heterociclicos y sus metodos de uso.
TW200745122A (en) New compounds I
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
MX340807B (es) Nuevas composiciones para prevenir y/o tratar trastornos degenerativos del sistema nervioso central.
CL2008003231A1 (es) Compuestos derivados de 1,3-dihidro-5-isobenzofurancarbonitrilo sustituido, inhibidores selectivos de la recaptacion de serotonina; composicion farmaceutica; procedimiento de preparacion; utiles en el tratamiento y/o prevencion de la eyaculacion prematura.
MX2007006042A (es) Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion.
TW200716153A (en) Mitotic kinesin inhibitors and methods of use thereof
TW200745133A (en) New compounds II
MY142082A (en) Substituted pyrroles, compositions containing them, method of manufacture and use
MX2009013126A (es) Nuevos compuestos 892.
WO2006128120A3 (en) Novel lapachone compounds and methods of use thereof
UA90656C2 (ru) Габоксадол для лечения депрессии
MEP1908A (xx) Gabaksadol za liječenje depresije i drugih afektivnih poremećaja
WO2009158387A3 (en) Compositions, formulations, and methods for preventing and/or treating physical effects of alcohol consumption
WO2007121883A3 (de) 1,4:3,6-dianhydromannitol-derivate und deren verwendung
TW200603791A (en) Compounds and compositions as cathepsin S inhibitors
CL2009001113A1 (es) Compuestos derivados de 4,5-diarilpirrol-2-carboxamida; procedimiento de preparacion de estos; composicion farmaceutica que los comprende; uso en el tratamiento y/o prevencion de trastornos psiquiatricos, dependencia a sustancias, entre otras.
WO2009105218A3 (en) Propiophenone derivatives